Angiotensin II-mediated posttranslational modification of nNOS in the PVN of rats with CHF: Role for PIN

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 305, Issue 6, 2013, Pages

  Sharma, Neeru M ^a   Llewellyn, Tamra L ^a   Zheng, Hong ^a   Patel, Kaushik P ^a  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

Author keywords

Angiotensin II; NNOS; Paraventricular nucleus; PIN; Sympathetic nerve activity

Indexed keywords

ANGIOTENSIN II; DIMER; LACTACYSTIN; MONOMER; NEURONAL NITRIC OXIDE SYNTHASE; PROTEIN; PROTEIN INHIBITOR OF NEURONAL NITRIC OXIDE SYNTHASE; UBIQUITIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN NUCLEUS; BRAIN REGION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DOWN REGULATION; HEART FAILURE; HEART INFARCTION SIZE; HEART LEFT VENTRICLE ENDDIASTOLIC PRESSURE; HEART MUSCLE CONTRACTILITY; IMMUNOPRECIPITATION; MALE; MOLECULAR MECHANICS; NERVE CELL CULTURE; NONHUMAN; PARAVENTRICULAR NUCLEUS; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RAT; UBIQUITINATION;

ANGIOTENSIN II; NNOS; PARAVENTRICULAR NUCLEUS; PIN; SYMPATHETIC NERVE ACTIVITY;

ANGIOTENSIN II; ANIMALS; CHRONIC DISEASE; CYTOPLASMIC DYNEINS; HEART FAILURE; MALE; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE I; PARAVENTRICULAR HYPOTHALAMIC NUCLEUS; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; UP-REGULATION;

EID: 84884388191     PISSN: 03636135     EISSN: 15221539     Source Type: Journal    
DOI: 10.1152/ajpheart.00170.2013     Document Type: Article

References (43)

1. Alderton WK, Cooper CE, Knowles RG. Nitric oxide synthases: structure, function and inhibition. Biochem J 357: 593-615, 2001.
2. Bender AT, Demady DR, Osawa Y. Ubiquitination of neuronal nitric oxide synthase in vitro and in vivo. J Biol Chem 275: 17407-17411, 2000.
3. Cai YC, Ma L, Fan GH, Zhao J, Jiang LZ, Pei G. Activation of N-methyl-d-aspartate receptor attenuates acute responsiveness of deltaopioid receptors. Mol Pharmacol 51: 583-587, 1997.
4. Dreyer J, Schleicher M, Tappe A, Schilling K, Kuner T, Kusumawidijaja G, Muller-Esterl W, Oess S, Kuner R. Nitric oxide synthase (NOS)-interacting protein interacts with neuronal NOS and regulates its distribution and activity. J Neurosci 24: 10454-10465, 2004.
5. Dumitrescu C, Biondi R, Xia Y, Cardounel AJ, Druhan LJ, Ambrosio G, Zweier JL. Myocardial ischemia results in tetrahydrobiopterin (BH4) oxidation with impaired endothelial function ameliorated by BH4. Proc Natl Acad Sci USA 104: 15081-15086, 2007.
6. Dunbar AY, Kamada Y, Jenkins GJ, Lowe ER, Billecke SS, Osawa Y. Ubiquitination and degradation of neuronal nitric-oxide synthase in vitro: dimer stabilization protects the enzyme from proteolysis. Mol Pharmacol 66: 964-969, 2004.
7. Fan JS, Zhang Q, Li M, Tochio H, Yamazaki T, Shimizu M, Zhang M. Protein inhibitor of neuronal nitric-oxide synthase, PIN, binds to a 17-amino acid residue fragment of the enzyme. J Biol Chem 273: 33472-33481, 1998.
8. Fishman MC, Zimmerman EA, Slater EE. Renin and angiotensin: the complete system within the neuroblastoma x glioma cell. Science 214: 921-923, 1981.
9. Furukawa M, Andrews PS, Xiong Y. Ubiquitin proteosome protocols. Methods Mol Biol 301: 37-46, 2005.
10. Gonçalves ARR, Fujihara CK, Matter AL, Malheiros DMAC, Noronha IL, De Nucci G, Zatz R. Renal expression of COX-2, ANG II, and AT1 receptor in remnant kidney: strong renoprotection by therapy with losartan and a nonsteroidal anti-inflammatory. Am J Physiol Renal Physiol 286: F945-F954, 2004.
11. Hamprecht B. Structural, electrophysiological, biochemical, and pharmacological properties of neuroblastoma-glioma cell hybrids in cell culture. Int Rev Cytol 49: 99-170, 1977.
12. Jaffrey SR, Benfenati F, Snowman AM, Czernik AJ, Snyder SH. Neuronal nitric-oxide synthase localization mediated by a ternary complex with synapsin and CAPON. Proc Natl Acad Sci USA 99: 3199-3204, 2002.
13. Jaffrey SR, Snowman AM, Eliasson MJ, Cohen NA, Snyder SH. CAPON: a protein associated with neuronal nitric oxide synthase that regulates its interactions with PSD95. Neuron 20: 115-124, 1998.
14. Jaffrey SR, Snyder SH. PIN: an associated protein inhibitor of neuronal nitric oxide synthase. Science 274: 774-777, 1996.
15. Klatt P, Pfeiffer S, List BM, Lehner D, Glatter O, Bachinger HP, Werner ER, Schmidt K, Mayer B. Characterization of heme-deficient neuronal nitric-oxide synthase reveals a role for heme in subunit dimerization and binding of the amino acid substrate and tetrahydrobiopterin. J Biol Chem 271: 7336-7342, 1996.
16. Klatt P, Schmidt K, Lehner D, Glatter O, Bachinger HP, Mayer B. Structural analysis of porcine brain nitric oxide synthase reveals a role for tetrahydrobiopterin and l-arginine in the formation of an SDS-resistant dimer. EMBO J 14: 3687-3695, 1995.
17. Kleiber AC, Zheng H, Schultz HD, Peuler JD, Patel KP. Exercise training normalizes enhanced glutamate-mediated sympathetic activation from the PVN in heart failure. Am J Physiol Regul Integr Comp Physiol 294: R1863-R1872, 2008.
18. 1 expression within the PVN in rats with heart failure. Am J Physiol Heart Circ Physiol 298: H1546-H1555, 2010.
19. Kojima H, Nakatsubo N, Kikuchi K, Kawahara S, Kirino Y, Nagoshi H, Hirata Y, Nagano T. Detection and imaging of nitric oxide with novel fluorescent indicators: diaminofluoresceins. Anal Chem 70: 2446-2453, 1998.
20. Laflamme L, Brechler V, Reudelhuber TL, Gallo-Payet N, Deschepper CF. The renin-angiotensin system in hybrid NG108-15 cells. Renin gene is from mouse neuroblastoma, angiotensinogen and angiotensin-converting enzyme genes are of rat glioma origin. Regul Pept 77: 9-15, 1998.
21. Li YF, Patel KP. Paraventricular nucleus of the hypothalamus and elevated sympathetic activity in heart failure: altered inhibitory mechanisms. Acta Physiol Scand 177: 17-26, 2003.
22. Li YF, Cornish KG, Patel KP. Alteration of NMDA NR1 receptors within the paraventricular nucleus of hypothalamus in rats with heart failure. Circ Res 93: 990-997, 2003.
23. Muller D, Greenland KJ, Speth RC, Middendorff R. Neuronal differentiation of NG108-15 cells has impact on nitric oxide-and membrane (natriuretic peptide receptor-A) cyclic GMP-generating proteins. Mol Cell Endocrinol 320: 118-127, 2010.
24. Noguchi S, Jianmongkol S, Bender AT, Kamada Y, Demady DR, Osawa Y. Guanabenz-mediated inactivation and enhanced proteolytic degradation of neuronal nitric oxide synthase. J Biol Chem 275: 2376-2380, 2000.
25. Ohkuma S, Katsura M, Chen DZ, Chen SH, Kuriyama K. Presence of N-methyl-d-aspartate (NMDA) receptors in neuroblastoma x glioma hybrid NG108-15 cells-analysis using [45Ca2+]influx and [3H]MK-801 binding as functional measures. Brain Res Mol Brain Res 22: 166-172, 1994.
26. Osawa Y, Lowe ER, Everett AC, Dunbar AY, Billecke SS. Proteolytic degradation of nitric oxide synthase: effect of inhibitors and role of Hsp90-based chaperones. J Pharmacol Exp Ther 304: 493-497, 2003.
27. Patel KP, Li YF, Hirooka Y. Role of nitric oxide in central sympathetic outflow. Proc Soc Exp Biol Med 226: 814-824, 2001.
28. Patel KP, Zhang PL, Krukoff TL. Alterations in brain hexokinase activity associated with heart failure in rats. Am J Physiol Regul Integr Comp Physiol 265: R923-R928, 1993.
29. Pfeffer MA, Pfeffer JM, Fishbein MC, Fletcher PJ, Spadaro J, Kloner RA, Braunwald E. Myocardial infarct size and ventricular function in rats. Circ Res 44: 503-512, 1979.
30. Rinetti GV, Schweizer FE. Ubiquitination acutely regulates presynaptic neurotransmitter release in mammalian neurons. J Neurosci 30: 3157-3166, 2010.
31. Rodriguez-Crespo I, Straub W, Gavilanes F, Ortiz de Montellano PR. Binding of dynein light chain (PIN) to neuronal nitric oxide synthase in the absence of inhibition. Arch Biochem Biophys 359: 297-304, 1998.
32. Rossi NF, Maliszewska-Scislo M, Chen H, Black SM, Sharma S, Ravikov R, Augustyniak RA. Neuronal nitric oxide synthase within paraventricular nucleus: blood pressure and baroreflex in two-kidney, one-clip hypertensive rats. Exp Physiol 95: 845-857, 2010.
33. Schelman WR, Kurth JL, Berdeaux RL, Norby SW, Weyhenmeyer JA. Angiotensin II type-2 (AT2) receptor-mediated inhibition of NMDA receptor signalling in neuronal cells. Brain Res Mol Brain Res 48: 197-205, 1997.
34. Schmidt TS, Alp NJ. Mechanisms for the role of tetrahydrobiopterin in endothelial function and vascular disease. Clin Sci (Lond) 113: 47-63, 2007.
35. Scott-Burden T. Regulation of nitric oxide production by tetrahydrobiopterin. Circulation 91: 248-250, 1995.
36. Sharma NM, Zheng H, Li YF, Patel KP. Nitric oxide inhibits the expression of AT1 receptors in neurons. Am J Physiol Cell Physiol 302: C1162-C1173, 2012.
37. Sharma NM, Zheng H, Mehta PP, Li YF, Patel KP. Decreased nNOS in the PVN leads to increased sympathoexcitation in chronic heart failure: role for CAPON and Ang II. Cardiovasc Res 92: 342-357, 2011.
38. Song T, Hatano N, Kume K, Sugimoto K, Yamaguchi F, Tokuda M, Watanabe Y. Inhibition of neuronal nitric-oxide synthase by phosphorylation at Threonine1296 in NG108-15 neuronal cells. FEBS Lett 579: 5658-5662, 2005.
39. Tallant EA, Diz DI, Khosla MC, Ferrario CM. Identification and regulation of angiotensin II receptor subtypes on NG108-15 cells. Hypertension 17: 1135-1143, 1991.
40. Zhang K, Li YF, Patel KP. Reduced endogenous GABA-mediated inhibition in the PVN on renal nerve discharge in rats with heart failure. Am J Physiol Regul Integr Comp Physiol 282: R1006-R1015, 2002.
41. Zhang K, Patel KP. Effect of nitric oxide within the paraventricular nucleus on renal sympathetic nerve discharge: role of GABA. Am J Physiol Regul Integr Comp Physiol 275: R728-R734, 1998.
42. Zheng H, Li YF, Cornish KG, Zucker IH, Patel KP. Exercise training improves endogenous nitric oxide mechanisms within the paraventricular nucleus in rats with heart failure. Am J Physiol Heart Circ Physiol 288: H2332-H2341, 2005.
43. Zheng H, Liu X, Li Y, Sharma NM, Patel KP. Gene transfer of neuronal nitric oxide synthase to the paraventricular nucleus reduces the enhanced glutamatergic tone in rats with chronic heart failure. Hypertension 58: 966-973, 2011.